Spots Global Cancer Trial Database for metastatic or locally advanced solid tumors
Every month we try and update this database with for metastatic or locally advanced solid tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab | NCT01285466 | Metastatic or L... | BEZ235 + paclit... BKM120 + paclit... BEZ235 + paclit... BKM120 + paclit... | 18 Years - | Novartis | |
A Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid Tumors | NCT05028556 | Metastatic or L... | Cohort 1 of Y10... Cohort 2 of Y10... Cohort 3 of Y10... Cohort 4 of Y10... Cohort 5 of Y10... | 18 Years - 75 Years | Wuhan YZY Biopharma Co., Ltd. | |
EVESOR: a Phase 1 Trial of Everolimus and Sorafenib | NCT01932177 | Metastatic or L... | Everolimus and ... Everolimus and ... Everolimus and ... Everolimus and ... | 18 Years - | Hospices Civils de Lyon | |
SHR-1701 in Metastatic or Locally Advanced Solid Tumors | NCT03710265 | Solid Tumor | SHR-1701 | 18 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. | |
A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab | NCT01285466 | Metastatic or L... | BEZ235 + paclit... BKM120 + paclit... BEZ235 + paclit... BKM120 + paclit... | 18 Years - | Novartis | |
Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors | NCT01170897 | Solid Tumor | PEGPH20 | 18 Years - | Halozyme Therapeutics |